These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 485367)

  • 21. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    Hum Reprod; 1994 Nov; 9(11):2167-72. PubMed ID: 7868693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy termination: techniques, risks, and complications and their management.
    Castadot RG
    Fertil Steril; 1986 Jan; 45(1):5-17. PubMed ID: 3510916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?
    Singh K; Fong YF; Prasad RN; Dong F
    Br J Obstet Gynaecol; 1999 Mar; 106(3):266-9. PubMed ID: 10426647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of damage to the cervix by dilatation for first-trimester-induced abortion by suction aspiration.
    Molin A
    Gynecol Obstet Invest; 1993; 35(3):152-4. PubMed ID: 8505006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uterine perforation following medical termination of pregnancy by vacuum aspiration.
    Mittal S; Misra SL
    Int J Gynaecol Obstet; 1985 Feb; 23(1):45-50. PubMed ID: 2860032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation.
    Ngai SW; Yeung KC; Lao T; Ho PC
    Contraception; 1995 Jun; 51(6):347-50. PubMed ID: 7554974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic antibiotics for curettage abortion.
    Grimes DA; Schulz KF; Cates W
    Am J Obstet Gynecol; 1984 Nov; 150(6):689-94. PubMed ID: 6388334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in therapeutic abortion in San Francisco.
    Goldstein P; Stewart G
    Am J Public Health; 1972 May; 62(5):695-9. PubMed ID: 5024298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fertility after contraception or abortion.
    Huggins GR; Cullins VE
    Fertil Steril; 1990 Oct; 54(4):559-73. PubMed ID: 2209874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mifepristone or vacuum aspiration in termination of early pregnancy.
    Legarth J; Peen UB; Michelsen JW
    Eur J Obstet Gynecol Reprod Biol; 1991 Sep; 41(2):91-6. PubMed ID: 1936497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second trimester pregnancy termination using extra-amniotic ethacridine lactate.
    Bhathena RK; Sheriar NK; Walvekar VR; Guillebaud J
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1026-9. PubMed ID: 2123711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immediate complications of surgical abortion].
    Soulat C; Gelly M
    J Gynecol Obstet Biol Reprod (Paris); 2006 Apr; 35(2):157-62. PubMed ID: 16575361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the methods for terminating pregnancy].
    Sadauskas VM; Chigreene VIu
    Akush Ginekol (Mosk); 1985 Mar; (3):37-9. PubMed ID: 3161362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of prostaglandin E1 analogue pessaries in patients having first trimester induced abortions.
    Nakano R; Hata H; Sasaki K; Yamoto M
    Br J Obstet Gynaecol; 1980 Apr; 87(4):287-91. PubMed ID: 7426498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three methods for gradual cervical dilatation prior to vacuum aspiration in late first trimester pregnancy.
    Sema S; Hingorani V; Kumar S; Kinra G
    Contraception; 1983 Sep; 28(3):223-31. PubMed ID: 6641223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
    Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J
    Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Legal abortion mortality.
    Kestelman P
    IPPF Eur Reg Inf; 1978 Apr; 7(2):8-9. PubMed ID: 12178337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW; Brown AH; Baird DT
    Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.